ARCHIVES

NCI To Proceed With Guidelines Unless Board Strongly Disagree

This article is from The Cancer Letter archive.

Vol. 06 No. 19 | May 9, 1980

Download PDF Visit The Full Archive

Related Articles

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

ASCO Issues RFP To Establish Washington Office

August 11, 1989

House: NCI Should Coordinate National Cancer Program

August 4, 1995